Carisma Therapeutics, Inc.
CARM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $44,717 | -$9,774 | -$9,266 | -$17,635 |
| Dep. & Amort. | $0 | $0 | $661 | $669 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $421 | $431 | $508 | $852 |
| Change in WC | $0 | -$1,395 | -$2,961 | $8,007 |
| Other Non-Cash | -$43,230 | $4,834 | $991 | -$245 |
| Operating Cash Flow | $1,908 | -$5,904 | -$10,067 | -$8,352 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $163 | $524 | $0 |
| Investing Cash Flow | $0 | $163 | $524 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$304 | -$271 |
| Stock Issued | $0 | $0 | $5 | -$23 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,130 | $0 | -$327 | -$326 |
| Financing Cash Flow | -$1,130 | $0 | -$626 | -$620 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $778 | -$5,741 | -$10,169 | -$8,972 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,999 | $7,740 | $17,909 | $26,881 |
| End Cash | $2,777 | $1,999 | $7,740 | $17,909 |
| Free Cash Flow | $1,908 | -$5,904 | -$10,067 | -$8,352 |